Navigation Links
Pennsylvania Patient Safety Authority Releases September Advisory
Date:9/16/2009

Pocono Medical Center and facilities in the northeast work together to reduce the number

of laboratory errors due to specimen mislabeling

HARRISBURG, Pa., Sept. 16 /PRNewswire-USNewswire/ -- Healthcare facilities in northeast Pennsylvania have come together to reduce and eliminate laboratory errors due to specimen mislabeling. Pocono Medical Center helped to spearhead the effort when they noticed they were reporting a large number of mislabeled lab specimens at their facility that coincided with data delivered in a presentation by the Pennsylvania Patient Safety Authority.

"The Authority spoke at an event for Pocono Medical Center in January and gave a presentation about Pennsylvania hospital data," Fran Charney, director of educational programs for the Pennsylvania Patient Safety Authority, said. "The Authority's specimen mislabeling data sparked a particular interest in Pocono and they approached the Authority to help improve patient safety in this area. The Authority agreed to facilitate a collaborative of area facilities to work on the issue."

Charney oversees the Authority's Patient Safety Liaison (PSL) program that has Authority representatives going into Pennsylvania's facilities to help them implement Pennsylvania Patient Safety Advisory guidance and improve patient safety processes. Pocono Medical Center's Patient Safety Officer (PSO) worked with the Northeast PSL, Megan Shetterly, to develop the collaboration.

Charney said analysis of Authority data shows that mislabeling events occur more often in the Emergency Department (ED) than other care areas, which is consistent with findings reported in literature that show laboratory samples drawn in the ED were 10 times more likely to be mislabeled. Specific to the northeast region, Authority analysis shows there is one mislabeling event reported per facility per month. Unfortunat
'/>"/>

SOURCE Pennsylvania Patient Safety Authority
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pennsylvania Breast Cancer Coalition Hosts Annual Conference
2. New Web Site Will Help Pennsylvanians Learn About, Protect Against Novel H1N1 Flu
3. Pennsylvanias Clean Indoor Air Act Marks One Year Anniversary
4. The Law Firm of Kelley & Murphy of Philadelphia, Blue Bell and Harrisburg has Filed a Law Suit in the United States District Court for the Eastern District of Pennsylvania
5. Philadelphia Attorney Carol Nelson Shepherd Presents at the 2009 Pennsylvania Association for Justice Master Series
6. Highmark Inc. Awards $7,500 to 15 Pennsylvania Nonprofit Organizations
7. Giant Eagle Pharmacy to Offer Customers in Pennsylvania a Dose of Economic Relief Through Free Antibiotics Program
8. Pennsylvania Department of Health Launches Online H1N1 Vaccine Registry
9. Join WQED Pittsburgh and The Press Club of Western Pennsylvania in Celebrating National Healthy Aging(R) Month and Kick Off Active Aging Week September 21-27
10. Pennsylvania Health Department Distributing Potassium Iodide to People Living, Working Near Nuclear Power Plants
11. Pennsylvania Governor Rendell Issues Statement on Senator Edward M. Kennedy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... Nov. 20 The American ...fy health care reform legislation released this we... insurance individual coverage mandate. The actuar... will minimize adverse selection stemming from mor... the bill. ,, "The individual mandate language ...
(Date:11/20/2009)..., Nov. 20 Following a recall by Un...oved from sale Shedd,s Country Crock ® Side D...ntry Crock ® Side Dishes DELUXE Four Cheese P... The following code dates and UPCs are affected: ,...UXE Cheddar Broccoli Rice 21 oz, UPC 027400218316,...
(Date:11/20/2009)....J., Nov. 20 Rates of in...peaked in late October, but the pandemic flu virus...all age groups, including the elderly, according t...NYSE: DGX ), the world,s leading provider of dia...In its most recent Quest Diagnostics Health Trends...
(Date:11/20/2009)... Nov. 20 Centene Corpo... present at the Bank of America Merrill Lynch 2009... at the Crowne Plaza Hotel Times Square in New Yor...mber 2nd at 8:30 a.m. Eastern Time. Investors and ...webcast of Centene,s presentation at: http://www....
(Date:11/20/2009)..., N.C., Nov. 20 Samuel ...redefine what it means to be "happy" during the ho...a specialty in family counseling and chair of the ..., Gladding says research shows that it is the pres...ven depression during the holidays. ,, That,s w...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2
... antibody drug to chemotherapy looks promising for...ding to Mayo Clinic researchers working with the N...://ncctg.mayo.edu/ ). Results of this interim anal...tients responded to treatment that included the dr...
...surgeries, researchers report , , FRIDAY,...ng rates, the number of mastectomies performed on ... Mayo Clinic now reports. , The increase coincid... at the American Society of Clinical Oncology (ASC...
... IDMI ) today announced that clinical data presen...idates will be made at the upcoming 44th,American .... Data presented,at the meeting will support impro... Presentation highlights are as follows:, L-MTP-P...
...s with metal complexes, scientists at The Wistar I...itor capable of blocking a biochemical pathway tha...d on studies in human melanoma cells, the research... of the study, to be published in the May 16 issue...
...y hospitals associated with Fox Chase Cancer Cente...een a major academic cancer center, where most new...spitals, where most care is provided, is a highly ...in Philadelphia, first established its network of ...
...edication also known by the trade name Celebrex, h...eration measurement of precancerous lesions in the... Texas M. D. Anderson Cancer Center. This finding ...is the first large randomized trial of Celebrex in...
Other Medicine News:Health News:Adding epratuzumab to standard therapy 2Health News:Mastectomies on the Increase 2Health News:Mastectomies on the Increase 3Health News:IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting 2Health News:IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting 3Health News:Novel enzyme inhibitor paves way for new cancer drug 2Health News:Novel enzyme inhibitor paves way for new cancer drug 3Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3
(Date:11/19/2009)..., Nov. 19 In a series of...nce, Heska Corporation (Nasdaq: HSKA ) ("Heska" o... new and improved website. The upgraded site is t...d programming to align the site with the company,s...(Logo: http://www.newscom.com/cgi-bin/prnh/20000...
(Date:11/19/2009)...., Nov. 19 The D e al...of its Most Admired Corporate Dealmakers for the s... as its Most Admired Dealmaker in pharma/biotech f...s and divestitures since January 2006. ,, Over ...portfolio with a focus on high-growth, innovation-...
(Date:11/19/2009)...., Nov. 19 Mach 7 Technologies, ...care image management solutions, and QStar Technol...ed PACS- neutral archive solution through their co...n international leader in providing digital image ...l industry. Under the agreement, Data Distributin...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4NexInfo Solutions Inc Selected by Beckman Coulter to Design and Streamline Global Sales 26 Operations Planning Processes 13597 1NexInfo Solutions Inc Selected by Beckman Coulter to Design and Streamline Global Sales 26 Operations Planning Processes 13597 2NexInfo Solutions Inc Selected by Beckman Coulter to Design and Streamline Global Sales 26 Operations Planning Processes 13597 3Hypertronics Circular HyperGrip 28R 29 Connectors Selected for Biosense Websters CARTO 28R 29 3 Navigation System 54663 1Hypertronics Circular HyperGrip 28R 29 Connectors Selected for Biosense Websters CARTO 28R 29 3 Navigation System 54663 2US born Asian American women more likely to think about attempt suicide 54659 1US born Asian American women more likely to think about attempt suicide 54659 2US born Asian American women more likely to think about attempt suicide 54659 3
...nd the European Organisation for the Research and ...llow-up results from the landmark Phase III,trial ...titute of Canada,(NCIC) that showed the combinatio...les and radiation therapy significantly prolonged,...(GBM) versus radiation,treatment alone and that a ...
... 6211 for the Potential Treatment of Pa...nd MUMBAI, India, Oct. 30 Eli,Lilly and Company (...nto an,agreement with Glenmark Pharmaceuticals S.A...rmaceuticals Limited India (GPL). Under the terms,... a portfolio of transient,receptor potential vanil...
Other Medicine Technology:Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 2Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 3Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 4Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme 5Lilly and Glenmark Pharmaceuticals Announce License Agreement 2Lilly and Glenmark Pharmaceuticals Announce License Agreement 3Lilly and Glenmark Pharmaceuticals Announce License Agreement 4Lilly and Glenmark Pharmaceuticals Announce License Agreement 5
...ORE-TEX Stretch Vascular Grafts have met the chall...ecognized for exceptional performance and quality,...eons worldwide. These grafts require no preclottin...and ensure utmost thrombectomy safety. The GORE-TE...
...oday's evolving techniques for vascular surgery, a... require that new, specialized types of graft be d...d biocompatible, but also available in varying siz.... GORE-TEX Vascular Graft has long been the prosth...
...ORE-TEX Vascular Grafts have met the challenges of...5 years. Recognized for exceptional performance an...owned surgeons worldwide. These grafts require no ...nfection, and assure utmost thrombectomy safety. T...
...ORE-TEX® Vascular Grafts have met the challeng...ver 25 years. Recognized for exceptional performan...f renowned surgeons worldwide. These grafts requir... of infection, and assure utmost thrombectomy safe...
Medicine Products: